Healthcare

As interest rates rise, with the potential for debt to become more expensive, operational talent and the ability to achieve revenue goals through improvements in operations becomes much more in focus.

Martis is among a handful of young firms seeking capital from limited partners who are generally sticking with their established relationships in the uncertain markets.

Cash-strapped LPs are 'having to make choices for the first time in a while,' CFO Jack Weingart said. 'What we see happening is those choices are benefiting the largest, most established GPs with the strongest relationships.'

Albaron is among a crop of first-timers braving the tough fundraising market to try to attract capital from picky LPs.

Experts say US-focused, non-tech, mid-market funds could do well in volatile environment.

Havencrest Capital Management, a Dallas-based healthcare private equity firm, has closed its second fund at a hard cap of $356 million, beating its $300 million target.

The fund is an example of the kind of specialized strategy that has been attracting attention from limited partners that are overburdened with re-ups from established firms.

Gilde Healthcare has closed its fourth healthcare private equity fund at 517 million euros.

Fund II’s rollout comes about two years after the close of RiverGlade’s inaugural fund. It secured $325m, ahead of an original target size of $300m.

Healthcare private equity fundraising has been strong this year – over the past three quarters, 177 funds globally raised about $165.7bn, the second-highest tally since 2008.